Lucid Diagnostics
LUCD
33 hedge funds and large institutions have $2.8M invested in Lucid Diagnostics in 2024 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 6 closing their positions.
83% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 6
40% more capital invested
Capital invested by funds: $2M → $2.8M (+$805K)
14% more funds holding
Funds holding: 29 → 33 (+4)
1.04% more ownership
Funds ownership: 4.54% → 5.58% (+1%)
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIG
Sargent Investment Group
Bethesda,
Maryland
|
+$478K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$106K |
| 3 |
SS
Sunbelt Securities
Houston,
Texas
|
+$74.1K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$58.2K |
| 5 |
Goldman Sachs
New York
|
+$56.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LM
Luminus Management
Houston,
Texas
|
-$120K |
| 2 |
LCS
Levin Capital Strategies
New York
|
-$54.2K |
| 3 |
Verition Fund Management
Greenwich,
Connecticut
|
-$32.4K |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$28.1K |
| 5 |
OIA
OneDigital Investment Advisors
Overland Park,
Kansas
|
-$9.09K |
LUCD Hedge Fund Activity: Q4 2024 in Review
33 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Lucid Diagnostics (LUCD) for Q4 2024, worth a combined $2.8M — up 40% from $2M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new LUCD positions and 6 closed out — a net gain of 5 holders — while 8 added to existing stakes and 8 trimmed.
The largest buyer was Sargent Investment Group, opening a new position worth an estimated $478K. The largest seller was Luminus Management, cutting an estimated $120K.
- 33 institutional investors held Lucid Diagnostics (LUCD) as of Q4 2024, up from 29 in Q3 2024.
- Funds reported $2.8M of Lucid Diagnostics stock for Q4 2024, up 40% quarter-over-quarter.
- 11 funds opened new Lucid Diagnostics positions in Q4 2024 and 6 closed out, a net change of +5 holders.
- The largest Lucid Diagnostics buyer in Q4 2024 was Sargent Investment Group, an estimated $478K added.
- The largest Lucid Diagnostics seller in Q4 2024 was Luminus Management, an estimated $120K sold.
Based on aggregated 13F filings for Q4 2024.